WO2000074573A1 - Pelvic displacement prosthesis for radioprotection of the small bowel - Google Patents
Pelvic displacement prosthesis for radioprotection of the small bowel Download PDFInfo
- Publication number
- WO2000074573A1 WO2000074573A1 PCT/US1999/012220 US9912220W WO0074573A1 WO 2000074573 A1 WO2000074573 A1 WO 2000074573A1 US 9912220 W US9912220 W US 9912220W WO 0074573 A1 WO0074573 A1 WO 0074573A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prosthesis
- affixed
- pelvis
- pelvic
- pelvic displacement
- Prior art date
Links
- 238000006073 displacement reaction Methods 0.000 title claims abstract description 49
- 230000001950 radioprotection Effects 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 20
- 210000004197 pelvis Anatomy 0.000 claims description 37
- 239000012530 fluid Substances 0.000 claims description 13
- 230000005540 biological transmission Effects 0.000 claims 2
- 230000005855 radiation Effects 0.000 description 23
- 210000000813 small intestine Anatomy 0.000 description 13
- 238000001802 infusion Methods 0.000 description 10
- 238000002350 laparotomy Methods 0.000 description 7
- 210000001165 lymph node Anatomy 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 210000003195 fascia Anatomy 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000003815 abdominal wall Anatomy 0.000 description 3
- 208000019065 cervical carcinoma Diseases 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 2
- 206010027459 Metastases to lymph nodes Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000002357 laparoscopic surgery Methods 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 210000004303 peritoneum Anatomy 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002747 omentum Anatomy 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/04—Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
- A61B2090/0409—Specification of type of protection measures
- A61B2090/0436—Shielding
- A61B2090/0454—Shielding by reflection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1094—Shielding, protecting against radiation
Definitions
- the present invention relates to a pelvic displacement prosthesis for radioprotection of the small intestines (bowel), and a method therefor, in which the prosthesis is inserted into the pelvis to elevate the small bowel out of the pelvic cavity during radiation therapy.
- Radiation can be an effective therapy in early stage cervical carcinoma and is the treatment of choice in later stage disease.
- the patient receives between 4500 and 5040 centiGray (rads) of radiation via external beam teletherapy to the whole pelvis followed with brachytherapy implants which are placed directly on the tumor.
- the purpose of the whole pelvic radiation is to sterilize microscopic disease which may be in the lymph nodes, as well as to shrink the size of the primary tumor.
- the dosage to the whole pelvis is calculated to be within small bowel tolerance to radiation.
- the other primary structures in the pelvis, the bladder and colon, have a greater tolerance to radiation. If the radiation dosage to the pelvis could be raised without increasing the rate of radiation-related bowel complications, then the curative potential of the radiation would be enhanced.
- a prosthetic bladder which is connected via tubing to a subcutaneous port so that the device can be insufflated or desufflated as needed during radiation therapy to elevate the small intestines out of the pelvic cavity.
- the device was used on 11 patients with none developing a complication in the follow-up period. The usual tolerable dose of radiation to the pelvis was increased in several patients secondary to the protection of the small intestine. This device was placed through a laparotomy and required a second small laparotomy to remove the instrument.
- an infusion port was placed beneath the skin of the abdomen to access the prosthetic bladder. This requires a separate incision to remove. While the inflated device did produce discomfort related to bowel and bladder pressure in some patients, inflation need occur only during the time the patient is receiving radiation, then the prosthetic bladder can be deflated for the remainder of the day.
- the prosthesis of the present invention integrates an expandable shell of sufficient shape and volume to elevate the small intestine out of the pelvic area during radiation when insufflated or filled.
- the prosthesis is connected via tubing to a valve or infusion port and can be filled with saline or other biologically compatible fluids.
- the tubing is located on the anterior or distal end of the device, so that, when the prosthesis is in place, the tubing will be located next to the anterior abdominal wall and away from the small intestine.
- the prosthesis of the present invention is designed so that, in its unfilled state, the prosthesis is of a size and shape that it can be placed and removed without a major surgical procedure.
- the device may be removed by pulling on the tubing to bring the prosthesis up through the fascia such that any shearing forces are away from the small intestine thereby minimizing the risk of tearing the bowel.
- the invention provides for a novel pelvic displacement prosthesis for radioprotection of the small bowel.
- the pelvic displacement prosthesis includes a hollow frustum- shaped shell.
- the pelvic displacement prosthesis includes a hollow shell and one or more manipulation loops affixed to the exterior thereof.
- the pelvic displacement prosthesis includes a hollow frustum-shaped shell and one or more manipulation loops affixed to the exterior thereof .
- the pelvic displacement prosthesis is inserted into the pelvis of a patient via an incision, laparotomy or laparoscopy.
- One or more manipulation loops are used to position the prosthesis within the pelvis. Fluid is supplied to or removed from the prosthesis through a tube connected to a valve or infusion port to insufflate or desufflate the shell. During treatment, radiation is applied to the desired area of the pelvis. Following treatment, the empty prosthesis is removed through an incision, laparotomy or laparoscopy using the tube or one or more of the manipulation loops.
- FIG. 1 is an elevation view of a pelvic displacement prosthesis embodying aspects of the invention.
- Fig. 2 is a plan view of a pelvic displacement prosthesis embodying aspects of the invention.
- This embodiment of the pelvic displacement prosthesis is expandable with a capacity on the order of 750 - 1500 cc without approaching its restrictive compliance (i.e. without approaching a shell's bursting point).
- the shape of the prosthesis is such that upon insufflation it will conform to the pelvic anatomy, such as a circular or other shaped frustum.
- the prosthesis may be made with one or more manipulation loops which can be sewn to the peritoneum at approximately the pelvic brim and at the base of the exenteration (tumor) site.
- This embodiment of the prosthesis is made of material safe for long-term (2-3 months) intraperitoneal placement, such as silicone elastomer.
- This embodiment of the prosthesis is minimally radio-opaque so that the pelvis can be evaluated by standard radiologic procedures if a problem were to develop while on therapy.
- This embodiment of the prosthesis is fluidly connected to an infusion port via silicone tubing approximately 24 inches long so that it can be safely routed to an exit site out of the radiation field.
- Fig. 1 is an elevation view
- Fig. 2 is a plan view, of a pelvic displacement prosthesis 100 embodying aspects of the present invention.
- the pelvic displacement prosthesis 100 includes shell 1, valve patch 2, manipulation loops 3a, 3b and tubing 6.
- Shell 1 has a hollow frustum, or truncated-cone, shape having an axis 8.
- the radius of the proximal end of shell is smaller than that of its distal end.
- the proximal and distal ends of shell 1 have outwardly-projecting shallow conical surfaces.
- the extreme distal end of shell 1 is reinforced by reinforcement sheet 5.
- Valve patch 2 is affixed via a fluid-tight connection to the distal end of shell 1.
- the axis of valve patch 2 is located at a radial distance A from the outer diameter of the distal end of shell 1.
- the connection between shell 1 and valve patch 2 is reinforced by reinforcement sheet 7.
- Tubing 6 is affixed via a fluid-tight connection to valve patch 2.
- Manipulation loop 3a is permanently affixed to the extreme proximal end of shell 1 along axis 8.
- Manipulation loop 3b is permanently affixed to the distal end of shell 1 at a radial distance B from the outer diameter of the distal end of shell 1.
- the attachments of manipulation loops 3a and 3b are reinforced by reinforcement sheets 9 and 10, respectively.
- the height of shell 1 is approximately 139 mm
- the diameters of the proximal and distal ends of shell 1 are approximately 83 mm and 153 mm, respectively
- radial distances A and B are 30 mm and 20 mm, respectively.
- the pelvic displacement prosthesis of the present invention is useful for patients undergoing surgical staging for advanced carcinoma of the cervix and other surgeries requiring radioprotection of the small bowel.
- patients first have a laparotomy performed with para-aortic lymph nodes removed via a retroperitoneal approach. Any large or suspicious lymph nodes in the pelvis will also be removed if at all feasible.
- the pelvic displacement prosthesis is placed, using manipulation loops 3a and 3b, into the pelvis and stitched, using absorbable sutures, onto the peritoneum and pelvis.
- the prosthesis is then insufflated with normal saline to a sufficient volume to displace the small intestine above the pelvic brim.
- the amount of fluid required is noted for each patient.
- the tubing of the prosthesis is brought up through the abdominal wall and attached to the fascia in a location outside the radiation field and connected to an infusion port.
- the prosthesis is tested prior to closure of the abdomen for ease of filling through the infusion port.
- the patients may have a small bowel radiographic series performed prior to radiation to document displacement of the small bowel by the pelvic displacement prosthesis.
- the pelvic displacement prosthesis may be insufflated with saline containing a small amount of radioopaque dye to aid in documenting displacement of the small bowel by the pelvic displacement prosthesis.
- a small incision over the infusion port is performed using local anesthesia and intravenous sedation.
- the infusion port is detached from the fascia and a small incision is made in the fascia just below this through which the pelvic displacement prosthesis is removed from the patient after desufflation of all the saline.
- the wound in the fascia and skin is closed in a customary fashion.
- the pelvic displacement prosthesis may be placed within the pelvis or removed therefrom laparoscopically, i.e. via a cannula or trocar.
- This pelvic displacement prosthesis and method have at least the following benefits:
- the most frequent cause of operation due to morbidity from radiation for cancer of the cervix involves small bowel injury.
- the small intestines are constantly moving with peristaltic activity and, therefore, should receive less radiation than the stationary structures of the pelvis.
- Volumes of the pelvis can range from 600-1000 cc.
- a device which can be expanded to 1500 cc will adequately elevate the small intestine out of the radiation field.
- the typical dose to the whole pelvis is sufficient to sterilize (i.e. kill) microscopic metastases of tumor to the pelvic lymph nodes.
- a significant number of patients are at risk for lymph node metastases that will recur in the pelvis, often in the area of the pelvic lymph nodes.
- the whole pelvic dose can be raised to the level of tolerance for the sigmoid colon - about 6000 rads - which should sterilize larger tumor volumes. This can have a significant impact on patient survival for those patients with unresectable or unresected lymph nodes, or those at high risk for having lymph node metastases. 3. Ease to patients.
- This device can be implanted at the time of laparotomy for staging of cervical cancer.
- the infusion port is brought out through the skin and secured with a suture to the anterior abdominal wall. This position assures that with insufflation of saline into the pelvic displacement prosthesis, the small intestines are elevated outside the pelvic cavity.
- the infusion port is then be tunneled under the skin to a separate exit site to decrease the likelihood of infection along the tubing. 4. Economics.
- the device can be removed in the office with local anesthesia, causing minimal inconvenience to patients. It is to be understood that the above-described embodiments are merely illustrative of the principles of the invention and that other arrangements may be devised by those skilled in the art without departing from the spirit and scope of the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/012220 WO2000074573A1 (en) | 1999-06-02 | 1999-06-02 | Pelvic displacement prosthesis for radioprotection of the small bowel |
AU43275/99A AU4327599A (en) | 1999-06-02 | 1999-06-02 | Pelvic displacement prosthesis for radioprotection of the small bowel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/012220 WO2000074573A1 (en) | 1999-06-02 | 1999-06-02 | Pelvic displacement prosthesis for radioprotection of the small bowel |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000074573A1 true WO2000074573A1 (en) | 2000-12-14 |
Family
ID=22272878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/012220 WO2000074573A1 (en) | 1999-06-02 | 1999-06-02 | Pelvic displacement prosthesis for radioprotection of the small bowel |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4327599A (en) |
WO (1) | WO2000074573A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102458A1 (en) * | 2001-06-15 | 2002-12-27 | Proxima Therapeutics, Inc. | Apparatus for protecting tissue from radiotherapy |
US7976554B2 (en) | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8001974B2 (en) | 2006-04-19 | 2011-08-23 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8192455B2 (en) | 2003-08-13 | 2012-06-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4643733A (en) * | 1983-04-04 | 1987-02-17 | Hilton Becker | Permanent reconstruction implant and method of performing human tissue expansion |
US4944749A (en) * | 1985-01-23 | 1990-07-31 | Hilton Becker | Implant and inflating construction |
US4950292A (en) * | 1988-04-20 | 1990-08-21 | Dow Corning Corporation | Tissue expanders |
US5337754A (en) * | 1991-11-25 | 1994-08-16 | Advanced Surgical, Inc. | Inflatable isolation bag |
US5735791A (en) * | 1997-01-31 | 1998-04-07 | Research Medical, Inc. | Inflatable heart elevation apparatus and method |
-
1999
- 1999-06-02 WO PCT/US1999/012220 patent/WO2000074573A1/en active Application Filing
- 1999-06-02 AU AU43275/99A patent/AU4327599A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4643733A (en) * | 1983-04-04 | 1987-02-17 | Hilton Becker | Permanent reconstruction implant and method of performing human tissue expansion |
US4944749A (en) * | 1985-01-23 | 1990-07-31 | Hilton Becker | Implant and inflating construction |
US4950292A (en) * | 1988-04-20 | 1990-08-21 | Dow Corning Corporation | Tissue expanders |
US5337754A (en) * | 1991-11-25 | 1994-08-16 | Advanced Surgical, Inc. | Inflatable isolation bag |
US5735791A (en) * | 1997-01-31 | 1998-04-07 | Research Medical, Inc. | Inflatable heart elevation apparatus and method |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673006B2 (en) | 2001-06-15 | 2004-01-06 | Proxima Therapeutics, Inc. | Tissue positioning apparatus and method for protecting tissue from radiotherapy |
US7494456B2 (en) | 2001-06-15 | 2009-02-24 | Cytyc Corporation | Tissue positioning systems and methods for use with radiation therapy |
WO2002102458A1 (en) * | 2001-06-15 | 2002-12-27 | Proxima Therapeutics, Inc. | Apparatus for protecting tissue from radiotherapy |
US8192455B2 (en) | 2003-08-13 | 2012-06-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8360069B2 (en) | 2006-04-19 | 2013-01-29 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8001974B2 (en) | 2006-04-19 | 2011-08-23 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US7976554B2 (en) | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8353925B2 (en) | 2006-04-19 | 2013-01-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8356605B2 (en) | 2006-04-19 | 2013-01-22 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8460321B2 (en) | 2006-04-19 | 2013-06-11 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US9155528B2 (en) | 2012-01-08 | 2015-10-13 | Vibrynt, Inc. | Methods, instruments and devices for extragastic reduction of stomach volume |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
Also Published As
Publication number | Publication date |
---|---|
AU4327599A (en) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100470519B1 (en) | Back-up retention member drainage catheter | |
US8900116B2 (en) | Inflatable stomal implant | |
JP4824090B2 (en) | Adjustable vaginal splint for pelvic floor support | |
JP3313112B2 (en) | Surgical apparatus and method | |
ES2303354T3 (en) | IMPLANTABLE AND ADJUSTABLE GENITOURINARY DEVICE. | |
Abu-Abeid et al. | Results and complications of laparoscopic adjustable gastric banding: an early and intermediate experience | |
JP2003510104A (en) | Apparatus and method for treating stress urinary incontinence, for example | |
US20080262406A1 (en) | Securement device for shunt catheter and implantation method therefor | |
WO2000074573A1 (en) | Pelvic displacement prosthesis for radioprotection of the small bowel | |
WO2004019765A2 (en) | Methods and devices for maintaining a space-occupying device within a stomach | |
US20170348089A1 (en) | Adjustable breast implant with integral injection port | |
US20050027161A1 (en) | Adjustable implantable genitourinary device | |
RU2372878C2 (en) | Adjustable bandage assembly method | |
BRPI0408904B1 (en) | Cystocele treatment implant and device for implant insertion | |
EP1607072B1 (en) | An improved fluid adjustable band | |
RU2160562C1 (en) | Method for making preperitoneal hernioplasty in the cases of inguinal hernia | |
RU2187970C1 (en) | Method for setting implant in performing preperitoneal hernioplasty | |
EP0837661A1 (en) | Implantable support device | |
Crabtree et al. | Laparoscopic implantation of swan neck presternal peritoneal dialysis catheters | |
Soper et al. | Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies | |
US20140243588A1 (en) | Implantable stoma ring | |
CN221205516U (en) | Automatic intestinal canal discharging device under expanding laparoscope | |
RU2522385C2 (en) | Method of suprapubic cystostomy in case of extraperitoneal breached integrity of urinary bladder walls | |
Rehman et al. | Robotic radical prostatectomy in patients with preexisting inflatable penile prosthesis (IPP) | |
US20060030818A1 (en) | System and method for securing a medical access device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |